Vargeese Chandra
Officer at WVE
- Sold, on record
- $880k
- Dollars the filings state
- Form 4 sales
- 12
- Latest Feb 9, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- WVEWave Life Sciences Ltd.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale WVEPlan not statedFeb 19, 2019 2019
Sold 2,055 shares at $36.84 ($76k)
Vargeese Chandra, Senior VP, Drug Discovery
Sold 7.5% of holdings ($1M position)25,245 shares left1x usual sizeFiling
- 2 Form 4 sale WVEPlan not statedDec 3, 2019 +287 days
Sold 6,000 shares at $35.00 ($210k)
Vargeese Chandra, Senior VP, Drug Discovery
Sold 13% of holdings ($1.6M position)40,245 shares left3x usual sizeFiling
- 3 Form 4 sale WVEPlan not statedFeb 18, 2020 +77 days
Sold 3,188 shares at $7.85 ($25k)
Vargeese Chandra, Senior VP, Drug Discovery
Sold 7.9% of holdings ($316k position)37,057 shares left1.1x usual sizeFiling
- 4 Form 4 sale WVEPlan not statedFeb 16, 2021 +364 days
Sold 3,145 shares at $10.57 ($33k)
Vargeese Chandra, Chief Technology Officer
Sold 3.6% of holdings ($936k position)85,412 shares left1x usual sizeFiling
- 5 Form 4 sale WVEPlan not statedFeb 16, 2022 +365 days
Sold 10,603 shares at $2.32 ($25k)
Vargeese Chandra, Chief Technology Officer
Sold 12% of holdings ($205k position)77,809 shares leftFiling
- 6 Form 4 sale WVEPlan not statedMay 5, 2022 +78 days
Sold 16,714 shares at $1.72 ($29k)
Vargeese Chandra, Officer
Sold 13.1% of holdings ($220k position)111,095 shares leftFiling
- 7 Form 4 sale WVEPlan not statedFeb 16, 2023 +287 days
Sold 10,249 shares at $4.03 ($41k)
Vargeese Chandra, Officer
Sold 8.8% of holdings ($471k position)106,624 shares left1x usual sizeFiling
- 8 Form 4 sale WVENo planFeb 9, 2026 +1089 days
Sold 3,228 shares at $13.45 ($43k)
Vargeese Chandra, Officer
No 10b5-1 planSold 0.8% of holdings ($5.5M position)408,246 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Feb 11, 2026 | WVE | Officer | Form 4 sale | 3,228 | $43k | 0.8% | No plan | SEC |
| Feb 16, 2023 | Feb 17, 2023 | WVE | Officer | Form 4 sale | 10,249 | $41k | 8.8% | Plan not stated | SEC |
| May 5, 2022 | May 6, 2022 | WVE | Officer | Form 4 sale | 16,714 | $29k | 13.1% | Plan not stated | SEC |
| Feb 16, 2022 | Feb 18, 2022 | WVE | Chief Technology Officer | Form 4 sale | 10,603 | $25k | 12.0% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 18, 2021 | WVE | Chief Technology Officer | Form 4 sale | 3,145 | $33k | 3.6% | Plan not stated | SEC |
| Feb 18, 2020 | Feb 20, 2020 | WVE | Senior VP, Drug Discovery | Form 4 sale | 3,188 | $25k | 7.9% | Plan not stated | SEC |
| Dec 3, 2019 | Dec 5, 2019 | WVE | Senior VP, Drug Discovery | Form 4 sale | 6,000 | $210k | 13.0% | Plan not stated | SEC |
| Feb 19, 2019 | Feb 21, 2019 | WVE | Senior VP, Drug Discovery | Form 4 sale | 2,055 | $76k | 7.5% | Plan not stated | SEC |
| Sep 24, 2018 | Sep 26, 2018 | WVE | Senior VP, Drug Discovery | Form 4 sale | 3,000 | $165k | 9.9% | Plan not stated | SEC |
| Feb 15, 2018 | Feb 20, 2018 | WVE | Officer | Form 4 sale | 2,000 | $100k | 6.8% | Plan not stated | SEC |
| Jan 23, 2018 | Jan 25, 2018 | WVE | Officer | Form 4 sale | 2,000 | $80k | 16.9% | Plan not stated | SEC |
| Nov 22, 2017 | Nov 22, 2017 | WVE | Officer | Form 4 sale | 1,500 | $53k | 100.0% | Unusual | SEC |